Other languages Beyond Air, Inc.

Equities

XAIR

US08862L1035

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
1.175 ^USD	-8.20%		-1.26%	-40.05%

Feb. 12	Beyond Air, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
Feb. 12	Beyond Air, Inc. Provides Revenue Guidance for the Fiscal Year 2025	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Beyond Air, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12
Beyond Air, Inc. Provides Revenue Guidance for the Fiscal Year 2025	Feb. 12
Beyond Air Affiliate Says First Group Cleared in Phase 1 UNO Study in Solid Tumors; Shares Rise	Dec. 27
Beyond Air Insider Bought Shares Worth $1,962,000, According to a Recent SEC Filing	Dec. 19
Beyond Air, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 13
Beyond Air, Inc. Provides Revenue Guidance for the Fiscal Year Ending March 31, 2025	Nov. 13
Beyond Air, Inc. Receives Innovative Technology Contract from Vizient for LungFit PH	23-10-16
EARNINGS: Andrews Sykes revenue up; Safestay optimistic	23-09-26
Beyond Air, Inc. Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder	23-09-18
Beyond Air, Inc. and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region	23-09-07
Insider Buy: Beyond Air	23-08-29
Beyond Air Files Shelf on Behalf of Selling Stockholders	23-08-14
Beyond Air, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10
Beyond Air Says Preclinical Data Showed Potential of Nitric Oxide in Autism Spectrum Disorder Treatment	23-08-08
Beyond Air, Inc. Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder	23-08-07
Beyond Air, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-23
Top Midday Decliners	23-06-23
Beyond Air Secures up to $40 Million Debt Financing From Avenue Capital Funds	23-06-15
Beyond Cancer Says Pre-Clinical Study for UNO Therapy in Solid Tumors Shows 'Promising' Data	23-04-19
Beyond Air, Inc. Appoints Jeff Myers as Chief Medical Officer	23-03-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Beyond Air, Inc.

Equities

XAIR

US08862L1035

Other languages

Filters